{
  "url": "https://www.law.cornell.edu/regulations/new-york/12-NYCRR-38.35",
  "title": "N.Y. Comp. Codes R. & Regs. Tit. 12 ยง 38.35 - Special requirements for specific licenses to manufacture or transfer certain items containing naturally occurring or accelerator produced radioactive material",
  "content": "N.Y. Comp. Codes R. & Regs. Tit. 12 ยง 38.35 - Special requirements for specific licenses to manufacture or transfer certain items containing naturally occurring or accelerator produced radioactive material\n\nState Regulations\n(a) Licenses for the introduction of radioactive material in exempt\nconcentrations into products or materials, and transfer of ownership or\npossession: (1)\n\nAn application for a\nspecific license authorizing the introduction of radioactive material into a\nproduct or material owned by or in the possession of the licensee or another\nperson, and the subsequent transfer of ownership or possession of the product\nor material to persons exempt under Table 1, Exemption 2 of section\n38.41\nof this Part will be\napproved if the applicant: (i) satisfies the\ngeneral requirements specified in section\n38.8\nof this Part; (ii)\nprovides a description of the product or\nmaterial into which the radioactive material will be introduced, intended use\nof the radioactive material and the product or material into which it is\nintroduced, method of introduction, initial concentration of the radioactive\nmaterial in the product or material, control methods to assure that no more\nthan the specified concentration is introduced into the product or material, estimated time interval between introduction and transfer of the product or\nmaterial, and estimated concentration of the radioisotopes in the product or\nmaterial at the time of transfer; and\n(iii)\nprovides reasonable assurance that the\nconcentrations of radioactive material at the time of transfer will not exceed\nthe concentrations in section\n38.41, Table 8 of this Part, that\nreconcentration of the radioactive material in concentrations exceeding those\nin Table 8 is not likely, that use of lower concentrations is not feasible, and\nthat the product or material is not likely to be incorporated in any food, beverage, cosmetic, drug or other commodity or product designed for ingestion\nor inhalation by, or application to, a human being. (2)\n\nEach person licensed under paragraph (1)\nof this subdivision shall maintain records of transfer of material, and file an\nannual report with the department which shall identify: (i) the type and quantity of each product or\nmaterial into which radioactive material has been introduced during the\nreporting period; (ii)\nthe name and\naddress of the person who owned or possessed the product or material, into\nwhich radioactive material has been introduced, at the time of\nintroduction; (iii)\nthe type and\nquantity of radionuclide introduced into each product or material; and\n(iv)\nthe initial concentrations\nof the radionuclide in the product or material at time of transfer of the\nradioactive material by the licensee. (3)\n\nThe report required by paragraph (2) of\nthis subdivison shall: (i) indicate whether\ntransfers of radioactive material were made pursuant to paragraph (1) of this\nsubdivision, during the reporting period; and\n(ii)\ncover the year ending June 30th, and be\nfiled by July 31st of the same year. (b) Licenses for the distribution of\nnaturally occurring and accelerator produced radioactive materials in exempt\nquantities. *\n(1)\n\nAn application for a specific license to\ndistribute radioactive materials to persons exempt under Table 1, Exemption 28\nof section\n38.41\nof this Part will be\napproved if: (i) the radioactive material is\nnot contained in any food, beverage, cosmetic, drug, or other commodity\ndesigned for ingestion or inhalation by, or application to, a human\nbeing; (ii)\nthe radioactive\nmaterial is in the form of processed chemical elements, compounds, or mixtures, tissue samples, bioassay samples, counting standards, plated or encapsulated\nsources, or similar substances, identified as radioactive and to be used for\nits radioactive properties, but is not incorporated into any manufactured or\nassembled commodity, product, or device intended for commercial distribution; and\n(iii)\nthe applicant submits\ncopies of prototype labels and brochures and the department approves such\nlabels and brochures. (2)\n\nEach license issued under paragraph (1) of this subdivision is subject to the\nfollowing conditions: (i) No more than 10\nexempt quantities shall be sold or transferred in any single transaction. For\npurposes of this requirement, an individual exempt quantity may be composed of\nfractional parts of one or more of the exempt quantities provided that the sum\nof such fractions shall not exceed unity. (ii)\n\nEach quantity of radioactive material\nshall be separately and individually packaged. No more than 10 such packaged\nexempt quantities shall be contained in any outer package for transfer to\npersons exempt pursuant to section\n38.41, Table 1, Exemption 28 of\nthis Part. The outer package shall be such that the dose rate at the external\nsurface of the package does not exceed 0.5 millirem per hour. (iii)\n\nThe immediate container of each\nquantity or separately packaged fractional quantity of radioactive material\nshall bear a durable, legible label which: (a) identifies the radioisotope and the quantity of radioactivity; and\n(b) bears the words \"Radioactive\n\nMaterial.\"\n(iv)\n\nIn\naddition to the labeling information required by subparagraph (2)(iii) of this\nsubdivision, the label affixed to the immediate container, or an accompanying\nbrochure, shall also: (a) state that the\ncontents are exempt from State licensing requirements; (b) bear the words \"Radioactive Material -\nNot for Human Use -Introduction Into Foods, Beverages, Cosmetics, Drugs, or\n\nMedicinals, or into Products Manufactured for Commercial Distribution is\n\nProhibited - Exempt Quantities Should Not be Combined;\" and\n(c) set forth appropriate additional\nradiation safety precautions and instructions relating to the handling, use, storage, and disposal of the radioactive material. (3)\n\nEach person licensed under\nparagraph (1) of this subdivision shall maintain records of transfer of\nmaterial identifying, by name and address, each person to whom radioactive\nmaterial was transferred for use under section\n38.41, Table 1, Exemption 28 of\nthis Part, or the equivalent regulations of any state, and stating the kinds\nand quantities of radioactive material transferred. The licensee shall maintain\nthe record of a transfer for a period of one year after the event is included\nin an annual summary report to the department. (4)\n\nThe annual report required by paragraph\n(3) of this subdivision shall: (i) indicate\nwhether transfers of radioactive material were made pursuant to paragraph (1)\nof this subdivision, during the reporting period; and\n(ii)\ncover the year ending June 30th, and be\nfiled by July 31st of the same year. (c) Licenses for the incorporation of\nradioactive material into gas and aerosol detectors. (1)\n\nAn application for a specific license to\nmanufacture, process, or produce gas and aerosol detectors containing\nradioactive material, or to initially transfer such products for use pursuant\nto section\n38.41, Table 1, Exemption 27 of\nthis Part or equivalent regulations of any state, will be approved if the\nmaximum quantity of radium 226 in each device does not exceed 0.1 microcurie, and if: (i) the applicant submits sufficient\ninformation relating to the design, manufacture, prototype testing, quality\ncontrol procedures, labeling or marking, and conditions of handling, storage, use, and disposal of the gas and aerosol detector to demonstrate that the\nproduct will meet the safety criteria set forth in paragraph (2) of this\nsubdivision. The information should include: (a) a description of the product and its\nintended use or uses; (b) the type\nand quantity of radioactive material in each unit; (c) the chemical and physical form of the\nradioactive material in the product and changes in chemical and physical form\nthat may occur during the useful life of the product; (d) solubility in water and body fluids of\nthe forms of the radioactive material identified in clauses\n(\nc\n) and (\nl\n) of this subparagraph; (e) details of construction and design of the\nproduct as related to containment and shielding of the radioactive material and\nother safety features under normal and severe conditions of handling, storage, use, and disposal of the product; (f) maximum external radiation levels at 5\nand 25 centimeters from any external surface of the product, averaged over an\narea not to exceed 10 square centimeters, and the method of\nmeasurement; (g) degree of access\nof human beings to the product during normal handling and use; (h) total quantity of radioactive material\nexpected to be distributed in the product annually; (i) the expected useful life of the\nproduct; (j) the proposed methods\nof labeling or marking the detector and its point-of-sale package to satisfy\nthe requirements of subparagraph (4)(ii) of this subdivision; (k) procedures for prototype testing of the\nproduct to demonstrate the effectiveness of the containment, shielding, and\nother safety features under both normal and severe conditions of handling, storage, use, and disposal of the product; (l) results of the prototype testing of the\nproduct, including any change in the form of the radioactive material contained\nin the product, the extent to which the radioactive material may be released to\nthe environment, any increase in external radiation levels, and any other\nchanges in safety features; (m) the\nestimated external radiation doses and other data relevant to the safety\ncriteria in paragraph (2) of this subdivision and the basis for such\nestimates; (n) a determination that\nthe probabilities with respect to the doses referred to in subparagraph\n(2)(iii) of this subdivision meet the criteria of that subparagraph; (o) quality control procedures to be followed\nin the fabrication of production lots of the product and the quality control\nstandards the product will be required to meet; and\n(p) any additional information, including\nexperimental studies and tests, required by the department. (2)\n\nSafety criteria. (i) An applicant for a license under this\nsubdivision shall demonstrate that the product is designed and will be\nmanufactured so that: (a) in normal use and\ndisposal of a single exempt unit, and in normal handling and storage of the\nquantities of exempt units likely to accumulate in one location during\nmarketing, distribution, installation, and servicing of the product, it is\nunlikely that the external radiation dose in any one year, or the dose\ncommitment resulting from the intake of radioactive material in any one year, to a suitable sample of the group of individuals expected to be most highly\nexposed to radiation or radioactive material from the product, will exceed the\ndose to the appropriate organ as specified in column I of the table in\nparagraph (3) of this subdivision; (b) it is unlikely that there will be a\nsignificant reduction in the effectiveness of the containment, shielding, or\nother safety features of the product from wear and abuse likely to occur in\nnormal handling and use of the product during its useful life; and\n(c) in use and disposal of a single exempt\nunit and in handling and storage of the quantities of exempt units likely to\naccumulate in one location during marketing, distribution, installation, and\nservicing of the product, the probability is low that the containment, shielding, or other safety features of the product would fail under such\ncircumstances that a person would receive an external radiation dose or dose\ncommitment in excess of the dose to the appropriate organ as specified in\ncolumn II of the table in paragraph (3) of this subdivision; and the\nprobability is negligible that a person would receive an external radiation\ndose or dose commitment in excess of the dose to the appropriate organ as\nspecified in column III of that table. *\n(3)\n\nTable of organ\ndoses. Part of body\n\nColumn I\n(rem)\n\nColumn II\n(rem)\n\nColumn III\n(rem)\n\nWhole body, head and trunk; active blood-forming\norgans; gonads; or lens of eye....... 0.005\n0.5\n15\n\nHands and forearms; feet and ankles; localized areas\nof skin averaged over areas no larger than one square centimeter....... 0.075\n7.5\n200\n\nOther organs....... 0.015\n1.5\n50\n(4)\n\nEach person licensed under this subdivision shall: (i) Carry out adequate control procedures in\nthe manufacture of the product to assure that each production lot meets the\nquality control standards approved by the department; (ii)\nlabel or mark each detector and its\npoint-of-sale package so that: (a) each\ndetector has a durable, legible, readily visible label or marking on the\nexternal surface of the detector containing: (1)\nthe following statement: \"Contains\n\nRadioactive Material;\"\n(2)\nthe name\nof the radionuclide and quantity of activity; and\n(3)\nan identification of the company licensed\nto transfer the detector for use pursuant to section\n38.41, Table 1, Exemption 27 of\nthis Part or equivalent regulations of another state; (b) the labeling or marking specified in\nclause (ii)(\na\n) of this paragraph is located where it will be\nreadily visible when the detector is removed from its mounting; (c) the external surface of the point-of-sale\npackage has a legible, readily visible label or marking containing: (1)\nthe name of the radionuclide and quantity\nof activity; (2)\nan identification\nof the person licensed under this subdivision to transfer the detector for use\npursuant to section\n38.41, Table 1, Exemption 27 of\nthis Part or equivalent regulations of the NRC or another state; and\n(3)\nthe following or a substantially similar\nstatement: \"This detector contains radioactive material and has been\nmanufactured in compliance with 12 NYCRR Part\n38, section\n38.35\n(c). The\npurchaser is exempt from any regulatory requirements;\"\n(d) each detector and point-of-sale package\nis provided with such other information as may be required by the department; and\n(iii)\nmaintain\nrecords and file a report with the department. (a) The report must include the following\ninformation on products transferred to other persons for use under section\n38.41, Table 1, Exemption 27 of\nthis Part or equivalent regulations of the USNRC or another state: (1)\na description or identification of the\ntype of each product; (2)\nfor each\nradionuclide in each type of product, the total quantity of the radionuclide; and\n(3)\nthe number of units of each\ntype of product transferred during the reporting period. (b) The licensee shall file the report within\n30 days following: (1)\nfive years after filing\nthe preceding report; or\n(2)\nnotifying the department of the licensee's decision to permanently discontinue\nactivities authorized pursuant to the license issued under this\nsubdivision. (c) The\nreport must cover the period between the filing of the preceding report and the\noccurrences specified in subclause (\nb\n)(\nl\n) or\n(\n2\n) of this subparagraph. If no transfers of radioactive\nmaterial have been made during the reporting period, the report must so\nindicate. (d) The licensee shall\nmaintain the record of a transfer for a period of one year after the event is\nincluded in a report to the department. (d) Licensing the\nmanufacture and commercial distribution of devices to persons generally\nlicensed under section\n38.41, Table 3, item (b) of this\n\nPart. (1)\n\nAn application for a\nspecific license to manufacture or commercially distribute devices containing\nradioactive material to persons generally licensed under section\n38.41, Table 3, item (b) of this\n\nPart or equivalent regulations of the USNRC or an agreement state, will be\napproved if: (i) the applicant satisfies the\ngeneral requirements of section\n38.8\nof this Part; (ii)\nthe applicant submits sufficient\ninformation relating to the design, manufacture, prototype testing, quality\ncontrol, labels, proposed uses, installation, servicing, leak testing, operating and safety instructions, and potential hazards of the device to\nprovide reasonable assurance that: (a) the\ndevice can be safely operated by persons not having training in radiological\nprotection; (b) under ordinary\nconditions of handling, storage, and use of the device, the radioactive\nmaterial contained in the device will not be released or inadvertently removed\nfrom the device, and it is unlikely that any person will receive in any period\nof one year a dose in excess of 10 percent of the limits specified in section\n38.18\n(a)(1)\nof\nthis Part; (c) under accident\nconditions (such as fire and explosion) associated with handling, storage, and\nuse of the device, it is unlikely that any person would receive an external\nradiation dose or dose commitment in excess of the following organ doses: Whole body; head and trunk active blood-forming\norgans; gonads; or lens of eye\n15 rems\n\nHands and forearms; feet and ankles; localized areas\nof skin averaged over areas no larger than one square centimeter\n200 rems\n\nOther organs\n50 rems\n(iii)\neach device bears a durable, legible, clearly visible label or labels approved by the department, which contain in a\nclearly identified and separate statement: (a) instructions and precautions necessary to\nassure safe installation, operation, and servicing of the device (documents\nsuch as operating and service manuals may be identified in the label and used\nto provide this information); (b) the requirement, or lack of requirement, for leak testing, or for testing any\n\"on-off\" mechanism and indicator, including the maximum time interval for such\ntesting, and the identification of radioactive material by isotope, quantity of\nradioactivity, and date of determination of the quantity; and\n(c) the information called for in one of the\nfollowing statements, as appropriate, in the same or substantially similar\nform: (1)\nfor radioactive material other than\nNARM: The receipt, possession, use, and transfer of this device, Model ___ *, Serial No. ___ *, are subject to a general license or the\nequivalent and the regulations of the USNRC or a state with which the\ncommission has entered into an agreement for the exercise of regulatory\nauthority. This label shall be maintained on the device in a legible condition. Removal of this label is prohibited. Caution-Radioactive Material\n______________\n(Name of Manufacturer or\n\nDistributor)\n*\n-OR-\n(2)\nfor NARM: The receipt, possession, use, and transfer of this device, Model ___ *, Serial No. ___ *, are subject to a general license or the\nequivalent, and the regulations of a State. This label shall be maintained on\nthe device in a legible condition. Removal of this label is prohibited. Caution-Radioactive Material\n______________\n(Name of Manufacturer or Distributor)*\n(2)\n\nIn the\nevent the applicant desires that the device be required to be tested at\nintervals longer than six months, either for proper operation of the \"on-off\"\nmechanism and indicator, if any, or for leakage of radioactive material or for\nboth, the applicant shall include in the application sufficient information to\ndemonstrate that such longer interval is justified by performance\ncharacteristics of the device or similar devices and by design features that\nhave a significant bearing on the probability or consequences of radioactive\nmaterial leakage from the device or failure of the \"on-off\" mechanism and\nindicator. In determining the acceptable interval for the test for radioactive\nmaterial leakage, the department will consider information that includes, but\nis not limited to: (i) primary containment\n(source capsule); (ii)\nprotection\nof primary containment; (iii)\nmethod of sealing containment; (iv)\ncontainment construction materials; (v) form of contained radioactive\nmaterial; (vi)\nmaximum temperature\nwithstood during prototype tests; (vii)\nmaximum pressure withstood during\nprototype tests; (viii)\nmaximum\nquantity of contained radioactive material; (ix)\nradiotoxicity of contained radioactive\nmaterial; and\n(x) operating\nexperience with identical devices or similarly designed and constructed\ndevices. (3)\n\nIn the event\nthe applicant desires that the general licensee under section\n38.41, Table 3, item (b) of this\n\nPart, or under equivalent regulations of the USNRC or another state be\nauthorized to collect the sample to be analyzed by a specific licensee for\nradioactive material leakage, perform maintenance of the device consisting of\nreplacement of labels, rust and corrosion prevention, and for fixed gauges, maintenance of source holder mounting brackets, test the \"on-off\" mechanism and\nindicator, the applicant shall include in the application written instructions\nto be followed by the general licensee, estimated calendar quarter doses\nassociated with such activity or activities, and bases for such estimates. The\nsubmitted information shall demonstrate that performance of such activity or\nactivities by an individual untrained in radiological protection, in addition\nto other handling, storage, and use of devices under the general license, is\nunlikely to cause that individual to receive a calendar quarter dose in excess\nof 10 percent of the limits specified in section\n38.18\n(a)(1)\nof\nthis Part. (4)\n\nEach person licensed\nunder this paragraph to commercially distribute devices to generally licensed\npersons shall: (i) furnish a copy of the\ngeneral license contained in section\n38.41, Table 3, item (b) of this\n\nPart to each person to whom the licensee directly, or through an intermediate\nperson, commercially distributes radioactive material in a device for use\npursuant to the general license; (ii)\nfurnish a copy of the general license\ncontained in the USNRC's, or a state's regulation equivalent to section\n38.41, Table 3, item (b) of this\n\nPart, or alternatively, furnish a copy of the general license contained in that\nsection to each person to whom the licensee directly, or through an\nintermediate person, commercially distributes radioactive material in a device\nfor use pursuant to the general license of the USNRC, this State or another\nstate. If a copy of the general license in section\n38.41, Table 3, item (b) of this\n\nPart is furnished to such a person, it shall be accompanied by an explanation\nthat the use of the device is regulated by the USNRC or a state under\nrequirements substantially the same as those in section\n38.41, Table 3, item (b) of this\n\nPart; (iii)\nreport to the\ndepartment all commercial distributions of such devices to persons for use\nunder the general license in section\n38.41, Table 3, item (b) of this\n\nPart. Such report shall identify each general licensee by name and address, an\nindividual by name and/or position who may constitute a point of contact\nbetween the department and the general licensee, the type, model, serial number\nof device and serial number of source commercially distributed, and the\nquantity and type of radioactive material contained in the device. If one or\nmore intermediate persons will temporarily possess the device at the intended\nplace of use prior to its possession by the user, the report shall also include\nidentification of each intermediate person by name, address, contact, and\nrelationship to the intended user. If no commercial distributions have been\nmade to persons generally licensed during the reporting period, the report\nshall so indicate. The report shall cover each calendar quarter and shall be\nfiled within 30 days thereafter; (iv)\n(a) report to the USNRC all commercial distributions of such devices to persons for\nuse under the NRC general license in\n10 CFR\n31.5; (b) report to the appropriate state all\ntransfers of devices manufactured and commercially distributed pursuant to this\nparagraph for use under a general license in that state's regulations\nequivalent to section\n38.41, Table 3, item (b) of this\n\nPart; (c) such reports shall\nidentify each general licensee by name and address, an individual by name\nand/or position who may constitute a point of contact between the agency and\nthe general licensee, the type model, serial number of the device and serial\nnumber of source commercially distributed, and the quantity and type of\nradioactive material contained in the device. If one or more intermediate\npersons will temporarily possess the device at the intended place of use prior\nto its possession by the user, the report shall also include identification of\neach intermediate person by name, address, contact, and relationship to the\nintended user. The report shall be submitted within 30 days after the end of\neach calendar quarter in which such a device is commercially distributed to the\ngenerally licensed person; and\n(d) if no commercial distributions have been made to USNRC or state licensees\nduring the reporting period, the fact that no such distributions have been made\nshall be reported to the USNRC and the states; and\n(v) keep records showing the name, address, and the point of contact for each general licensee to whom the licensee\ndirectly, or through an intermediate person, commercially distributes\nradioactive material in devices for use pursuant to the general license\nprovided in section\n38.41, Table 3, item (b) of this\n\nPart, or equivalent regulations of the USNRC or another state. The records\nshould show the date of each commercial distribution, the isotope and the\nquantity of radioactivity in each device commercially distributed, the identity\nof any intermediate person, and compliance with the reporting requirements of\nthis paragraph. (e) Luminous safety devices for use\nin aircraft: requirements for license to manufacture, assemble, repair or\ninitially transfer. (1)\n\nAn\napplication for a specific license to manufacture, assemble, repair or\ninitially transfer luminous safety devices containing tritium or promethium-147\nfor use in aircraft, for distribution to persons generally licensed under\nsection\n38.41, Table 3, item (e) of this\n\nPart, will be approved if: (i) the applicant\nsatisfies the general requirements specified in section\n38.8\nof this Part; (ii)\nthe applicant submits sufficient\ninformation regarding each device pertinent to evaluation of the potential\nradiation exposure, including: (a) chemical\nand physical form and maximum quantity of tritium or promethium-147 in each\ndevice; (b) details of construction\nand design; (c) details of the\nmethod of binding or containing the tritium or promethium-147; (d) procedures for, and results of, prototype\ntesting to demonstrate that the tritium or promethium-147 will not be released\nto the environment under the most severe conditions likely to be encountered in\nnormal use; (e) any quality control\nprocedures proposed as alternatives to those prescribed by paragraph (4) of\nthis subdivision; and\n(f) any\nadditional information, including experimental studies and tests, required by\nthe department to facilitate a determination of the safety of the\ndevice; (iii)\neach device\nwill contain no more than 10 curies of tritium or 300 millicuries of\npromethium-147. The levels of radiation from each device containing\npromethium-147 will not exceed 0.5 millirad per hour at 10 centimeters from any\nsurface when measured through 50 milligrams per square centimeter of absorber; and\n(iv)\nthe department determines\nthat: (a) the method of incorporation and\nbinding of the tritium or promethium-147 in the device is such that the tritium\nor promethium-147 will not be released under the most severe conditions which\nare likely to be encountered in normal use and handling of the\ndevice; (b) the tritium or\npromethium-147 is incorporated or enclosed so as to preclude direct physical\ncontact by any person with it; (c) the device is so designed that it cannot easily be disassembled; and\n(d) the of device has been subjected to and\nhas satisfactorily passed the prototype tests prescribed by schedule B of part\n32 of the\n\nCode of Federal Regulations; January 1, 1995\nedition\n1. (2)\nA person licensed under this subdivision\nto manufacture, assemble, or initially transfer devices containing tritium or\npromethium-147 for distribution to persons generally licensed under section\n38.41, Table 3, item (e) of this\n\nPart shall, except as provided in paragraph (3) of this subdivision, affix to\neach device a label containing the radiation symbol prescribed by section\n38.25\nof this Part, such other\ninformation as may be required by the department including disposal\ninstructions when appropriate, and the following or a substantially similar\nstatement which contains the information called for in the following statement: The receipt, possession, use, and transfer of this device, Model ___ *, Serial No. ___* containing ___ (identity and quantity of\nradioactive material) are subject to a general license or the equivalent and\nthe regulations of the USNRC or of a state with which the NRC has entered into\nan agreement for the exercise of regulatory authority. Do not remove this\nlabel. Caution-Radioactive Material\n__________________\n(Name of manufacturer, assembler, or initial\ntransferor.)\n*\n(3)\n\nIf the department determines that it is\nnot feasible to affix a label to the device containing all the information\ncalled for in paragraph (2) of this subdivision, it may waive the requirements\nof that paragraph and require in lieu thereof that: (i) a label be affixed to the device\nidentifying: (a) the manufacturer, assembler, or initial transferor; and\n(b) the\ntype of radioactive material; (ii)\na leaflet bearing the following\ninformation be enclosed in or accompany the container in which the device is\nshipped: (a) the name of the manufacturer, assembler, or initial transferor; (b) the type and quantity of radioactive\nmaterial; (c) the model\nnumber; (d) a statement that the\nreceipt, possession, use, and transfer of the device are subject to a general\nlicense or the equivalent and the regulations of the USNRC or of an agreement\nstate; and\n(e) such other\ninformation as may be required by the department including disposal\ninstructions when appropriate. (4)\n\nQuality assurance. (i) Each person licensed under this\nsubdivision shall visually inspect each device and shall reject any which has\nan observable physical defect that could affect containment of the tritium or\npromethium-147. (ii)\n\nEach person\nlicensed under this subdivision shall take a random sample of the size required\nby the table for \"Lot Tolerance Percent Defective of 5.0 percent\" in subpart C\nof part 32 of the\n\nCode of Federal Regulations; January 1, 1995\nedition\n1, from each inspection lot, and shall\nsubject each unit in the sample to the following tests: (a) each device shall be immersed in 30\ninches of water for 24 hours and shall show no visible evidence of water entry. Absolute pressure of the air above the water shall then be reduced to one inch\nof mercury. Lowered pressure shall be maintained for one minute or until air\nbubbles cease to be given off by the water, whichever is the longer. Pressure\nshall then be increased to normal atmospheric pressure. Any device which leaks\nas evidenced by bubbles emanating from within the device, or water entering the\ndevice, shall be considered as a defective unit; (b) the immersion test water from the\npreceding test in clause (\na\n) of this subparagraph shall be\nmeasured for tritium or promethium-147 content by an apparatus that has been\ncalibrated to measure tritium or promethium-147, as appropriate. If more than\n0.1 percent of the original amount of tritium or promethium-147 in any device\nis found to have leaked into the immersion test water, the leaking device shall\nbe considered as a defective unit; and\n(c) the levels of radiation from each device\ncontaining promethium-147 shall be measured. Any device which has a radiation\nlevel in excess of 0.5 millirad per hour at 10 centimeters from any surface\nwhen measured through 50 milligrams per square centimeter of absorber, shall be\nconsidered as a defective unit. (iii)\n\nAn application for a license, or for\namendment of a license, may include a description of procedures proposed as\nalternatives to those prescribed by subparagraph (ii) of this paragraph, and\nproposed criteria for acceptance under those procedures. The department will\napprove the proposed alternative procedures if the applicant demonstrates that: (a) they will consider defective any sampled\ndevice which has a leakage rate exceeding 0.1 percent of the original quantity\nof tritium or promethium-147 in any 24-hour period; and\n(b) the operating characteristic curve or\nconfidence interval estimate for the alternative procedures provides a \"Lot\n\nTolerance Percent Defective of 5.0 percent\" at the consumer's risk of\n0.10. (iv)\n\nNo person\nlicensed under this subdivision shall transfer to persons generally licensed\nunder section\n38.41, Table 3, item (e) of this\n\nPart: (a) any luminous safety device which has\nbeen tested and found defective under the criteria and procedures specified in\nthis section, unless the defective units have been repaired or reworked and\nhave then met the tests set out in subparagraph (ii) of this paragraph; or\n(b) any inspection lot which has\nbeen rejected as a result of the procedures in subparagraph (ii) of this\nparagraph, or alternative procedures in subparagraph (iii) of this paragraph; unless the defective units have been sorted and removed or have been repaired\nor reworked and have then met the tests set out in subparagraph (ii) of this\nparagraph. (5)\n\nMaterial transfer reports. Each person licensed under this subdivision shall\nfile an annual report with the department which shall state the total quantity\nof tritium or promethium-147 transferred to persons generally licensed under\nsection\n38.41, Table 3, item (e) of this\n\nPart. The report shall identify each general licensee by name, state the kinds\nand numbers of luminous devices transferred, and specify the quantity of\ntritium or promethium-147 in each kind of device. Each report shall cover the\nyear ending June 30th and shall be filed within 30 days thereafter. (f) Requirements for a\nlicense to manufacture or initially transfer calibration or reference sources\ncontaining americium-241, plutonium or radium-226. (1)\n\nAn application for a specific license to\nmanufacture or initially transfer calibration or reference sources containing\namericium-241, plutonium or radium-226, for distribution to persons generally\nlicensed under section\n38.41, Table 3, item (f) of this\n\nPart, will be approved if: (i) the applicant\nsatisfies the general requirements of section\n38.8\nof this Part; (ii)\nthe applicant submits sufficient\ninformation regarding each type of calibration or reference source pertinent to\nevaluation of the potential radiation exposure, including: (a) chemical and physical form and maximum\nquantity of radioactive material in the source; (b) details of construction and\ndesign; (c) details of the method\nof incorporation and binding of the radioactive material in the\nsource; (d) procedures for, and\nresults of, prototype testing of sources, which are designed to contain more\nthan 0.005 microcurie of radioactive material, to demonstrate that the\nradioactive material contained in each source will not be released or be\nremoved from the source under normal conditions of use; (e) details of quality control procedures to\nbe followed in manufacture of the source; (f) a description of labeling to be affixed\nto the source or the storage container for the source; and\n(g) any additional information, including\nexperimental studies and tests, required by the dpartment to facilitate a\ndetermination of the safety of the source; (iii)\neach source will contain no more than\nfive microcuries of radioactive material; (iv)\nthe department determines, with respect\nto any type of source containing more than 0.005 microcurie of radioactive\nmaterial, that: (a) the method of\nincorporation and binding of the radioactive material in the source is such\nthat the radioactive material will not be released or be removed from the\nsource under normal conditions of use and handling of the source; and\n(b) the source has been subjected to and has\nsatisfactorily passed prototype tests. The following prototype tests shall be\nconducted, in the order listed, on each of five prototypes of such source: (1)\n\nInitial measurement. The quantity of\nradioactive material deposited on the source shall be measured by direct\ncounting of the source. (2)\n\nDry\nwipe test. The entire radioactive surface of the source shall be wiped with\nfilter paper with the application of moderate finger pressure. Removal of\nradioactive material from the source shall be determined by measuring the\nradioactivity on the filter paper or by direct measurement of the radioactivity\non the source following the dry wipe. (3)\n\nWet wipe test. The entire radioactive\nsurface of the source shall be wiped with filter paper, moistened with water, with the application of moderate finger pressure. Removal of radioactive\nmaterial from the source shall be determined by measuring the radioactivity on\nthe filter paper after it has dried or by direct measurement of the\nradioactivity on the source following the wet wipe. (4)\n\nWater soak test. The source shall be\nimmersed in water at room temperature for a period of 24 consecutive hours. The\nsource shall then be removed from the water. Removal of radioactive material\nfrom the source shall be determined by direct measurement of the radioactivity\non the source after it has dried or by measuring the radioactivity in the\nresidue obtained by evaporation of the water in which the source was\nimmersed. (5)\n\nDry wipe test. On\ncompletion of the preceding test in this section, the dry wipe test described\nin subclause (2) of this clause shall be repeated. (6)\n\nObservations. Removal of more than 0.005\nmicrocurie of radioactivity in any test prescribed by this clause shall be\ncause for rejection of the source design. Results of prototype tests submitted\nto the department shall be given in terms of radioactivity in microcuries and\npercent of removal from the total amount of radioactive material deposited on\nthe source. (2)\n\nLabeling of devices. (i) Each person licensed under this\nsubdivision shall affix to each source, or storage container for the source, a\nlabel which shall contain sufficient information relative to safe use and\nstorage of the source and shall include the following statement, or a\nsubstantially similar statement which contains the information called for in\nthe following statement: The receipt, possession, use and transfer of this source, Model ___, Serial No. ___, are subject to a general license and the regulations\nof the USNRC or of a state with which the commission has entered into an\nagreement for the exercise of regulatory authority. Do not remove this\nlabel. Caution-Radioactive Material-this source contains\n____. Do not touch radioactive portion of this source\n____________________\n(Name of manufacturer or initial transferor)\n(3)\n\nLeak testing of each\nsource. (i) Each person licensed under this\nsubdivision shall perform a dry wipe test upon each source containing more than\n0.1 microcurie of radioactive material prior to transferring the source to a\ngeneral licensee under section\n38.41, Table 3, item (f) of this\n\nPart. This test shall be performed by wiping the entire radioactive surface of\nthe source with a filter paper with the application of moderate finger\npressure. The radioactivity on the paper shall be measured by using radiation\ndetecting instrumentation capable of detecting 0.005 microcurie of the\ncontained radioactive material. If any such test discloses more than 0.005\nmicrocurie of radioactive material, the source shall be deemed to be leaking or\nlosing radioactive material and shall not be transferred to a general\nlicensee. (g) Manufacture and commercial distribution of radioactive material for\ncertain in vitro clinical or laboratory testing under a general license. An application for a specific license to manufacture or\ncommercially distribute radioactive material for use under the general license\nof section\n38.41, Table 3, item (h) of this\n\nPart will be approved if: (1)\nthe\napplicant satisfies the general requirements specified in section\n38.8\nof this Part; (2)\nthe radioactive material is to be\nprepared for distribution in prepackaged units of: (i) iodine-125 in units not exceeding 10\nmicrocuries each; (ii)\niodine-131\nin units not exceeding 10 microcuries each; (iii)\ncarbon-14 in units not exceeding 10\nmicrocuries each; (iv)\nhydrogen-3\n(tritium) in units not exceeding 50 microcuries each; (v) iron-59 in units not exceeding 20\nmicrocuries each; (vi)\ncobalt-57 in\nunits not exceeding 10 microcuries each; (vii)\nselenium-75 in units not exceeding 10\nmicrocuries each; or\n(viii)\nmock\niodine-125 in units not exceeding 0.05 microcurie of iodine-129 and 0.005\nmicrocurie of americium-241 each; (3)\neach prepackaged unit bears a durable, clearly visible label: (i) identifying the\nradioactive contents as to chemical form and radionuclide, and indicating that\nthe amount of radioactivity does not exceed 10 microcuries of iodine-125, iodine-131, carbon-14, cobalt-57, or selenium-75; 50 microcuries of hydrogen-3\n(tritium); 20 microcuries of iron-59; or mock iodine-125 in units not exceeding\n0.05 microcurie of iodine-129 and 0.005 microcurie of americium-241; and\n(ii)\ndisplaying the radiation\ncaution symbol described in section\n38.25\n(a) of this\n\nPart and the words, \"Caution, Radioactive Material,\" and \"Not for Internal or\n\nExternal Use in Humans or Animals;\" and\n(4)\none of the following statements, as\nappropriate, or a substantially similar statement that contains the information\ncalled for in one of the following statements, appears on a label affixed to\neach prepackaged unit or appears in a leaflet or brochure that accompanies the\npackage: (i) This radioactive material may be\nreceived, acquired, possessed, and used only by physicians, veterinarians, clinical laboratories, or hospitals, and only for in vitro clinical or\nlaboratory tests not involving internal or external administration of the\nmaterial, or the radiation therefrom, to human beings or animals. Its receipt, acquisition, possession, use, and transfer are subject to the regulations and a\ngeneral license of the USNRC or of a state with which the USNRC has entered\ninto an agreement for the exercise of regulatory authority. __________\nName of Manufacturer\n-OR-\n(ii)\n\nThis radioactive material may be\nreceived, acquired, possessed, and used only by physicians, veterinarians, clinical laboratories, or hospitals and only for in vitro clinical or\nlaboratory tests not involving internal or external administration of the\nmaterial, or the radiation therefrom, to human beings or animals. Its receipt, acquisition, possession, use, and transfer are subject to the regulations and a\ngeneral license of a state. __________\nName of Manufacturer\n-AND-\n(5)\n\nThe label affixed to the unit, or the\nleaflet or brochure that accompanies the package, contains adequate information\nas to the precautions to be observed in handling and storing such radioactive\nmaterial. In the case of a mock iodine-125 reference or calibration source, the\ninformation accompanying the source must also contain directions to the\nlicensee regarding the waste disposal requirements of section\n38.20\nof this Part. (h) Ice detection devices\ncontaining strontium-90; requirements for a license to manufacture or initially\ntransfer. (1)\n\nAn application for a\nspecific license to manufacture or initially transfer ice detection devices\ncontaining strontium-90 for distribution to persons generally licensed under\nsection\n38.41, Table 3, item (c) of this\n\nPart will be approved if: (i) the applicant\nsatisfies the general requirements specified in section\n38.8\nof this Part; (ii)\nthe applicant submits sufficient\ninformation regarding each type of device pertinent to evaluation of the\npotential radiation exposure, including: (a) the chemical and physical form and maximum quantity of strontium-90 in the\ndevice; (b) details of construction\nand design of the source of radiation and its shielding; (c) the radiation profile of a prototype\ndevice; (d) procedures for and\nresults of prototype testing of devices to demonstrate that the strontium-90\ncontained in each device will not be released or be removed from the device\nunder the most severe conditions likely to be encountered in normal handling\nand use; (e) details of quality\ncontrol procedures to be followed in manufacture of the device; (f) a description of labeling to be affixed\nto the device; (g) instructions for\nhandling and installation of the device; and\n(h) any additional information, including\nexperimental studies and tests, required by the department to facilitate a\ndetermination of the safety of the device; (iii)\neach device will contain no more than\n50 microcuries of strontium-90 in an insoluble form; (iv)\neach device will bear durable, legible\nlabeling which includes the radiation caution symbol prescribed by Section\n38.25\n(a) of this\n\nPart, a statement that the device contains strontium-90 and the quantity\nthereof, instructions for disposal and statements that the device may be\npossessed pursuant to a general license, that the manufacturer or civil\nauthorities should be notified if the device is found, that removal of the\nlabeling is prohibited and that disassembly and repair of the device may be\nperformed only by a person holding a specific license to manufacture or service\nsuch devices; and\n(v) the\ndepartment determines that: (a) the method of\nincorporation and binding of the strontium-90 in the device is such that the\nstrontium-90 will not be released from the device under the most severe\nconditions which are likely to be encountered in normal use and handling of the\ndevice; (b) the strontium-90 is\nincorporated or enclosed so as to preclude direct physical contact by any\nindividual with it and is shielded so that no individual will receive a\nradiation exposure to a major portion of his body in excess of 0.5 rem in a\nyear under ordinary circumstance of use; (c) the device is so designed that it cannot\nbe easily disassembled; (d) the\ndevice has been subjected to and has satisfactorily passed the prototype tests\nprescribed by section 32.103 schedule D of part 32 of the Code of Federal\n\nRegulations; January 1, 1995 edition\n1; and\n(e) quality control procedures have been\nestablished to satisfy the requirements of paragraph (2) of this\nsubdivision. (2)\n\nQuality assurance. (i) Each person licensed under this\nsubdivision shall visually inspect each device and shall reject any which has\nan observable physical defect that could affect containment of the\nstrontium-90. (ii)\n\nEach person\nlicensed under this subdivision shall test each device for possible loss of\nstrontium-90 or for contamination by wiping with filter paper an area of at\nleast 100 square centimeters on the outside surface of the device, or by wiping\nthe entire surface area if it is less than 100 square centimeters. The\ndetection on the filter paper of more than 2,200 disintegrations per minute of\nradioactive material per 100 square centimeters of surface wiped shall be cause\nfor rejection of the tested device. (iii)\n\nEach person licensed under this\nsubdivision shall take a random sample of the size required by the table for\n\"Lot Tolerance Percent Defective of 5.0 percent\" in subpart C of part 32 of the\n\nCode of Federal Regulations; January 1, 1995\nedition\n1, from each inspection lot, and shall\nsubject each unit in the sample to the following tests: (a) Each device shall be immersed in 30\ninches of water for 24 hours and shall show no visible evidence of physical\ncontact between the water and the strontium-90. Absolute pressure of the air\nabove the water shall then be reduced to one inch of mercury. Lowered pressure\nshall be maintained for one minute or until air bubbles cease to be given off\nby the water, whichever is the longer. Pressure shall then be increased to\nnormal atmospheric pressure. Any device which leaks, as evidenced by physical\ncontact between the water and the strontium-90, shall be considered as a\ndefective unit. (b) The immersion\ntest water from the preceding test in paragraph (c)(1) of this section shall be\nmeasured for radioactive material. If the amount of radioactive material in the\nimmersion test water is greater than 0.1 percent of the original amount of\nstrontium-90 in any device, the device shall be considered as a defective\nunit. (iv)\n\nAn application\nfor a license or for amendment of a license may include a description of\nprocedures proposed as alternatives to those prescribed by subparagraph\n(2)(iii) of this subdivision, and proposed criteria for acceptance under those\nprocedures. The department will approve the proposed alternative procedures if\nthe applicant demonstrates that: (a) they\nwill consider defective any sampled device which has a leakage rate exceeding\n0.1 percent of the original quantity of strontium-90 in any 24-hour period; and\n(b) the operating\ncharacteristic curve or confidence interval estimate for the alternative\nprocedures provides a \"Lot Tolerance Percent Defective of 5.0 percent\" at the\nconsumer's risk of 0.10. (v) No person licensed under this subdivision\nshall transfer to persons generally licensed under section\n38.41, Table 3, item (c) of this\n\nPart: (a) any device which has been tested and\nfound defective under the criteria and procedures specified in this subdivision\nunless the defective units have been repaired or reworked and then met the\ntests set out in subparagraph (2)(iii) of this subdivision; or\n(b) any inspection lot which has been\nrejected as a result of the procedures in subpart C of part 32 of the Code of\n\nFederal Regulations; January 1, 1995 edition\n1, or\nalternative procedures in subparagraph (iv) of this paragraph, unless the\ndefective units have been sorted and removed, or have been repaired or reworked\nand have then met the tests set out in subparagraph (2)(iii) of this\nsubdivision. (i) Manufacture and distribution of\nsources or devices containing radioactive material for medical use. (1)\n\nAn application for a specific license to\nmanufacture and distribute sources and devices containing radioactive material\nto persons licensed pursuant to part 35 of the Code of Federal Regulations or\nthe equivalent regulations of any state, for use as a calibration or reference\nsource or for medical diagnosis or therapy, will be approved if: (i) the applicant satisfies the general\nrequirements in section\n38.8\nof this Part; (ii)\nthe applicant submits sufficient\ninformation regarding each type of source or device pertinent to an evaluation\nof its radiation safety, including: (a) the\nradioactive material contained, its chemical and physical form, and\namount; (b) details of design and\nconstruction of the source or device; (c) procedures for, and results of, prototype\ntests to demonstrate that the source or device will maintain its integrity\nunder stresses likely to be encountered in normal use and accidents; (d) the radiation profile of a prototype\ndevice; (e) details of quality\ncontrol procedures to assure that production sources and devices meet the\nstandards of the design and prototype tests; (f) procedures and standards for calibrating\nsources and devices; (g) legend and\nmethods for labeling sources and devices as to their radioactive content; and\n(h) instructions for handling\nand storing the source or device from the radiation safety standpoint; these\ninstructions are to be included on a durable label attached to the source or\ndevice or attached to a permanent storage container for the source or device; provided that instructions which are too lengthy for such label may be\nsummarized on the label and printed in detail on a brochure which is referenced\non the label; and\n(iii)\nthe label affixed to the source or device, or to the permanent storage\ncontainer for the source or device, contains information on the radionuclide, quantity and date of assay, and a statement that the department has approved\ndistribution of the (name of source or device) to persons licensed to use\nradioactive material identified in section 35.58, 35.400 or 35.500, as\nappropriate, of part 35 of the Code of Federal Regulations or the equivalent\nregulations of a state. (2)\n(i) In\nthe event the applicant desires that the source or device be required to be\ntested for leakage of radioactive material at intervals longer than six months, he or she shall include in the application sufficient information to\ndemonstrate that such longer interval is justified by performance\ncharacteristics of the source or device or similar sources or devices and by\ndesign features that have a significant bearing on the probability or\nconsequences of leakage of radioactive material from the source. (ii)\n\nIn determining the acceptable interval\nfor test of leakage of radioactive material, the department will consider\ninformation that includes, but is not limited to: (a) primary containment (source\ncapsule); (b) protection of primary\ncontainment; (c) the method of\nsealing containment; (d) containment construction materials; (e) the form of contained radioactive\nmaterial; (f) the maximum\ntemperature withstood during prototype tests; (g) the maximum pressure withstood during\nprototype tests; (h) the maximum\nquantity of contained radioactive material; (i) the radiotoxicity of contained\nradioactive material; and\n(j) operating experience with identical sources or devices or similarly designed\nand constructed sources or devices. (j) Manufacture, preparation or\ntransfer for commercial distribution of drugs containing radioactive material\nfor medical use under part 35 of the Code of Federal Regulations or the\nequivalent regulations of any state. (1)\n\nAn application for a specific license to\nmanufacture, prepare, or transfer for commercial distribution radioactive drugs\ncontaining radioactive material for use by persons authorized pursuant to part\n35 of the Code of Federal Regulations or the equivalent regulations of any\nstate will be approved if: (i) the applicant\nsatisfies the general requirements specified in section\n38.8\nof this Part; (ii)\nthe applicant submits evidence that the\napplicant is registered or licensed by the New York State Board of Pharmacy as\na drug manufacturer or a pharmacy, as appropriate to their practice; (iii)\nthe applicant submits information on\nthe radionuclide; the chemical and physical form; the maximum activity per\nvial, syringe, generator, or other container of the radioactive drug; and the\nshielding provided by the packaging to show it is appropriate for the safe\nhandling and storage of the radioactive drugs by medical use licensees; and\n(iv)\nthe applicant satisfies\nthe following labeling requirements: (a) a\nlabel is affixed to each transport radiation shield, whether it is constructed\nof lead, glass, plastic, or other material, of a radioactive drug to be\ntransferred for commercial distribution. The label must include the radiation\nsymbol and the words \"Caution, Radioactive Material\" or \"Danger, Radioactive\n\nMaterial;\" the name of the radioactive drug or its abbreviation; and the\nquantity of radioactivity at a specified date and time. For radioactive drugs\nwith a half-life greater than 100 days, the time may be omitted; and\n(b) a label is affixed to each syringe, vial, or other container used to hold a radioactive drug to be transferred for\ncommercial distribution. The label must include the radiation symbol and the\nwords \"Caution, Radioactive Material\" or \"Danger, Radioactive Material\" and an\nidentifier that ensures that the syringe, vial, or other container can be\ncorrelated with the information on the transport radiation shield\nlabel. (2)\nA\nlicensee shall possess and use instrumentation to measure the radioactivity of\nradioactive drugs. The licensee shall have procedures for use of the\ninstrumentation. The licensee shall measure, by direct measurement or by\ncombination of measurements and calculations, the amount of radioactivity in\ndosages of alpha-, beta-, or photon-emitting radioactive drugs prior to\ntransfer for commercial distribution. In addition, the licensee shall: (i) perform tests before initial use, periodically, and following repair, on each instrument for accuracy, linearity, and geometry dependence, as appropriate for the use of the instrument; and make\nadjustments when necessary; (ii)\ncheck each instrument for constancy and proper operation at the beginning of\neach day of use; and\n(iii)\nuse\ndiffering activity concentrations in preparing different radiopharmaceuticals, and ensure that any discrepancy between the calculated volume of a dosage and\nthe volume found to be required by measurement to achieve the prescribed\nactivity, is resolved before the dosage is dispensed. Records of actions taken\nto resolve any such discrepancy shall be maintained for three years. (3)\nA licensee shall possess and\nuse instrumentation for performing surveys and analyses for radioactive\ncontamination, and for making such measurements of radiation levels and\nradiation dose as may be necessary to demonstrate compliance with all\nrequirements of this Part. In addition, the licensee shall: (i) provide appropriate instrumentation for\neach application. This must include but is not limited to: a microrem meter for\nsurveying non-radioactive trash before disposal, and for surveying workers'\nskin and clothing for contamination; a thyroid uptake system with a\nreproducible geometry and an adequate lower limit of detection; and analytical\ninstruments for identifying and quantifying radioactive contamination; and\n(ii)\ncalibrate all instruments\nin accordance with the manufacturer's specifications, and calibrate all meters\nat least every 12 months. (4)\n(i) A\nlicensee shall provide a radiation safety officer who is a health physicist\nwith qualifications listed in subparagraph (iii) of this paragraph. (ii)\nA licensee shall only allow persons who\nare certified by the New York State Board of Pharmacy as nuclear pharmacists to\nact as pharmacists in a facility licensed pursuant to this subdivision. A\nlicensee may also propose such a certified nuclear pharmacist as radiation\nsafety officer provided that the nuclear pharmacist will be assisted in the\nadministration of the radiation protection program by a health physicist with\nthe qualifications listed in subparagraph (iii) of this paragraph, and who will\nbe present at the licensee's facility for the equivalent of one working day per\nmonth at a minimum, and who will provide the following services: (a) provide classroom instruction to\nnon-professional personnel who will perform work under the license; (b) review personnel monitoring reports and\nrecommend methods to reduce exposures exceeding ALARA levels; (c) review survey records and make\nconfirmatory measurements; (d) review air monitoring and emission levels and ensure compliance with\nlimits; (e) assist in thyroid\nbioassays and review absorbed dose calculations; (f) observe operations and make\nrecommendations for improvements; (g) assist in response to, and in the\nevaluation of root causes and impacts of, incidents and accidents in order to\nminimize their impact and prevent their recurrence; and\n(h) generally consult with the RSO and\nprovide health physics support as needed. The services to be provided must be\ndocumented in a contractual agreement between the licensee and the health\nphysicist, and the department must be given a minimum of 30 days advance notice\nof the licensee's intent to retain a different health physicist. (iii)\nA health physicist who will\nact as radiation safety officer, or who will provide the services described in\nsubparagraph (ii) of this paragraph, must have the following qualifications: (a) experience in performing radiation\nprotection services, or the duties of a radiation safety officer for programs\nof similar type, size and scope as the licensee's program; and\n(b) a Bachelor's degree in health physics or\nradiological health and four years of the experience as described in clause\n(\na\n) of this subparagraph; or certification by the American\n\nBoard of Health Physics (Comprehensive), the American Board of Radiology in\n\nMedical Nuclear Physics, the American Board of Science in Nuclear Medicine in\n\nRadiation Protection or the American Board of Medical Physics in Medical Health\n\nPhysics, and two years of the experience as described in clause\n(\na\n) of this subparagraph. (5)\n(i) A\nlicensee shall only locate a nuclear pharmacy in a building that is zoned for\ncommercial use, and which is not in a heavy public traffic area such as a large\nshopping center. (ii)\nA licensee\nwho proposes to locate within a multi-tenant building must demonstrate that: (a) there are no areas above or below the\nproposed facility which are not under the licensee's control, and to which the\nlicensee does not have the authority to restrict access; and\n(b) there are no neighboring tenants on the\nsame level with walls contiguous to the proposed radioactive materials use and\nstorage areas. There must be a buffer zone of unrestricted area within the\nlicensee's proposed facility along any walls that are common walls with a\nneighboring tenant. Footnotes\n* Authority to transfer possession or control by the\nmanufacturer, processor, or producer of any equipment, device, commodity, or\nother product containing byproduct material whose subsequent possession, use, transfer, and disposal by all other persons are exempted from regulatory\nrequirements may be obtained only from the United States Nuclear Regulatory\n\nCommission, Washington, D.C. 20555. * It is the intent of this subparagraph that as the\nmagnitude of the potential dose increases above that permitted under normal\nconditions, the probability that any individual will receive such a dose must\ndecrease. The probabilities have been expressed in general terms to emphasize\nthe approximate nature of the estimates which are to be made. The following\nvalues may be used as guides in estimating compliance with the criteria: Low -\nnot more than one such failure per year for each 10,000 exempt units\ndistributed. Negligible -not more than one such failure per year for each one\nmillion exempt units distributed. * The model, serial number, and name of manufacturer or\ndistributor may be omitted from this label provided they are elsewhere stated\nin labeling affixed to the device. 1 The documents referenced in this Part are available for\nreview and copying at the Department of Labor, State Campus, Bldg. 12, Rm. 509, Albany, NY or the Department of State, 41 State St., Albany, NY. * The model, serial number, and name of manufacturer, assembler, or initial transferor may be omitted from this label provided they\nare elsewhere specified in labeling affixed to the device. 1 The documents referenced in this Part are available for\nreview and copying at the Department of Labor, State Campus, Bldg. 12, Rm. 509, Albany, NY or the Department of State, 41 State St., Albany, NY. 1 The documents referenced in this Part are available for\nreview and copying at the Department of Labor, State Campus, Bldg. 12, Rm. 509, Albany, NY or the Department of State, 41 State St., Albany, NY. Notes\nN.Y. Comp. Codes R. & Regs. Tit. 12\nยง\n38.35\n\nState regulations are updated quarterly; we currently have two versions available. Below is a\ncomparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare. No prior version found.",
  "url_type": "regulation",
  "source_index": 1691
}